FibroGen, Inc. (LON:0IL8)
London · Delayed Price · Currency is GBP · Price in USD 6.98
-0.07 (-1.06%)
At close: Aug 1, 2025
FibroGen Market Cap
FibroGen has a market cap or net worth of 21.02 million as of August 4, 2025. Its market cap has decreased by -74.31% in one year.
Market Cap
21.02M
Enterprise Value
96.20M
Revenue
5.41M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.98
Market Cap Chart
Since November 14, 2014, FibroGen's market cap has decreased from 1.25B to 21.02M, a decrease of -98.31%. That is a compound annual growth rate of -31.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 21.02M | -50.67% |
| Dec 31, 2024 | 42.62M | -37.71% |
| Dec 29, 2023 | 68.43M | -94.52% |
| Dec 30, 2022 | 1.25B | 29.40% |
| Dec 31, 2021 | 965.40M | -60.95% |
| Dec 31, 2020 | 2.47B | -12.50% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 172.19B |
| GSK plc | 56.39B |
| Haleon | 32.84B |
| Smith & Nephew | 10.12B |
| ConvaTec Group | 4.72B |
| Hikma Pharmaceuticals | 4.27B |
| HUTCHMED (China) | 2.26B |
| Oxford Nanopore Technologies | 1.92B |